Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04831320
Title Nab-Paclitaxel in Combination With Nivolumab to Treat Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma That Progressed on a PD-1 or PD-L1 Inhibitor
Recruitment Recruiting
Gender
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

oral squamous cell carcinoma

hypopharynx cancer

laryngeal squamous cell carcinoma

head and neck squamous cell carcinoma

oropharynx cancer

Therapies

Nab-paclitaxel + Nivolumab

Age Groups:
Covered Countries USA


No variant requirements are available.